10.1002/chem.202000893
Chemistry - A European Journal
Full Paper
(silica gel, PE/EA = 20:1, Rf = 0.50) afforded 6 as a yellow viscous oil
1
(582 mg, 1.10 mmol, 54%). H NMR (400 MHz, CDCl3) δ 10.42 (s, 1H),
7.41 (d, J = 8.7 Hz, 1H), 7.32 – 7.27 (m, 1H), 7.25 – 7.03 (m, 3H), 6.67 –
6.40 (m, 3H), 4.17 – 3.93 (m, 4H), 3.39 – 3.20 (m, 4H), 1.91 – 1.74 (m,
4H), 1.63 – 1.47 (m, 8H), 1.42 – 1.26 (m, 12H), 0.92 (m, 12H). 13C NMR
(100 MHz, CDCl3) δ 189.4, 189.2, 156.6, 155.8, 151.1, 150.5, 148.5,
147.7, 136.2, 135.9, 132.9, 132.8, 130.5, 128.5, 124.5, 123.9, 123.7,
123.4, 120.7, 117.6, 114.8, 111.7, 111.1, 110.2, 109.9, 109.7, 69.4, 69.3,
50.9, 31.7, 29.7, 29.4, 26.0, 22.8, 20.5, 14.2, 14.1. IR (cm−1): 2955, 2928,
2870, 1682, 1612, 1519, 1466, 1366, 1214, 1186, 811. HRMS (DART):
m/z [M+H]+ calcd for C35H54NO3 536.4098, found 536.4101.
Experimental Section
General Procedure 1 (GP1): Synthesis of intermediates 4-6 by Heck
reaction. The reaction was performed in a heat-gun-dried 50 mL Schlenk
tube under a nitrogen atmosphere. The brominated intermediate (1.0 eq)
and the vinyl compound (1.14 eq) were dissolved in dry DMF. Pd(OAc)2
(5 mol%), tris(o-tolyl)phosphine (0.1 eq) and dry triethylamine (0.8 mL)
were added and the mixture was stirred at 110 °C for 48 h. After the
reaction mixture was cooled to ambient temperature, it was poured into
water to give a suspension which was extracted with DCM. The
combined organic layers were washed with brine, dried over MgSO4 and
the solvents were removed under reduced pressure. The residues were
purified by column chromatography.
1,3,5-Tris((E)-2,5-bis(hexyloxy)-4-((E)-styryl)styryl)benzene
(Y0).
According to GP2 a solution of triphosphonate 7 (42.3 mg, 80.0 µmol) in
dry THF (8 mL) was treated with NaH (28.8 mg, 1.20 mmol) and
monoaldehyde 4 (105 mg, 256 µmol) was added. The crude product was
purified by column chromatography (silica gel, PE/EA = 20:1, Rf = 0.41)
to yield the desired compound Y0 as a yellow green powder (79.6 mg,
61.6 µmol, 77%). M.p.: 110-111 °C. 1H NMR (600 MHz, CDCl3) δ 7.66 –
7.49 (m, 15H), 7.39 (t, J = 7.6 Hz, 6H), 7.32 – 7.22 (m, 6H), 7.22 – 7.14
(m, 9H), 4.11 (dd, J = 15.1, 6.6 Hz, 12H), 1.99 – 1.85 (m, 12H), 1.59 (td,
J = 13.5, 7.0 Hz, 12H), 1.48 – 1.34 (m, 24H), 0.93 (dt, J = 25.7, 6.8 Hz,
18H). 13C NMR (150 MHz, CDCl3) δ 151.3, 151.2, 138.7, 138.1, 129.0,
128.9, 128.7, 127.5, 127.1, 126.6, 124.1, 123.6, 111.0, 110.8, 69.7, 31.7,
29.5, 26.1, 22.8, 14.2. IR (cm−1): 2926, 2856, 2360, 1419, 1199, 958, 750,
690, 598, 506. HRMS (MALDI): m/z [M]+ calcd for C91H114O6 1290.8615,
found 1290.947.
General Procedure 2 (GP2): Synthesis of symmetric Y0, Y3 and YNBu by
Wittig-Horner reaction. Under nitrogen atmosphere, the triphosphonate 7
(1.0 eq) was dissolved in dry THF and the solution was cooled to 0 °C.
NaH (15.0 eq) was added carefully and the mixture was stirred at 0 °C for
40 min before the monoaldehyde 4-6 (4.5 eq) was added slowly. The
reaction mixture was then allowed to warm to RT and further stirred for 3
days. After removing THF on a rotary evaporator, the residues were
purified on silica gel column.
4,4'-((1E,1'E)-(2,5-bis(hexyloxy)-1,4-phenylene)bis(ethene-2,1-
diyl))dipyridine (L2a). Under nitrogen atmosphere, a solution of 2 (218
mg, 500 μmol), 4-vinylpyridine (118 mg, 1.20 mmol), Pd(OAc)2 (11.2 mg,
50 μmol), tris(o-tolyl)phosphine (30.4 mg, 100 μmol) and triethylamine
(1.20 mL) in dry DMF (10 mL) was stirred at 110 °C for 48 h. After the
reaction mixture was cooled to ambient temperature, it was poured into
water to give a suspension which was extracted with DCM. The
combined organic layers were washed with brine dried over MgSO4 and
the solvents were removed under reduced pressure. The residues were
purified by column chromatography (silica gel, DCM/EE = 5:1, Rf = 0.21)
and afforded L2a as a yellow solid (110 mg, 225 μmol, 45%). M.p.: 135-
136 °C. 1H NMR (300 MHz, CDCl3) δ 8.58 (d, J = 6.0 Hz, 4H), 7.70 (s,
1H), 7.64 (s, 1H), 7.38 (d, J = 6.0 Hz, 4H), 7.18 – 7.08 (m, 3H), 7.05 (s,
1H), 4.08 (t, J = 6.5 Hz, 4H), 1.95 – 1.82 (m, 4H), 1.63 – 1.49 (m, 4H),
1.47 – 1.33 (m, 8H), 0.93 (t, J = 7.0 Hz, 6H). 13C NMR (100 MHz, CDCl3)
δ 151.7, 150.1, 149.8, 145.4, 129.7, 128.3, 128.2, 127.6, 126.9, 126.7,
126.5, 126.0, 123.6, 121.0, 114.6, 114.1, 111.2, 110.9, 69.7, 31.8, 29.5,
26.1, 22.8, 14.2. IR (cm−1): 2942, 2915, 2360, 1592, 1476, 1209, 1028,
968, 850, 803, 596, 525. HRMS (MALDI): m/z [M+H]+ calcd for
C32H41N2O2 485.3168, found 485.372.
1,3,5-Tris((E)-2,5-bis(hexyloxy)-4-((E)-2-(pyridin-4-
yl)vinyl)styryl)benzene (Y3). According to GP2
a
solution of
triphosphonate 7 (42.3 mg, 80.0 µmol) in dry THF (8 mL) was treated
with NaH (28.8 mg, 1.20 mmol) and monoaldehyde 5 (114.7 mg, 280
µmol) was added. The crude product was purified by column
chromatography (silica gel, DCM/MeOH = 50:1, Rf = 0.35) to yield the
desired compound Y3 as an orange solid (34.9 mg, 26.9 µmol, 33%).
M.p.: 122–123 °C. 1H NMR (600 MHz, CDCl3) δ 8.58 – 8.50 (d, J = 5.4
Hz, 6H), 7.71 – 7.39 (m, 12H), 7.23 – 6.63 (m, 15H), 4.01 – 3.93 (m,
12H), 1.91 – 1.83 (m, 12H), 1.58 (m, 12H), 1.39 – 1.27 (m, 24H), 0.96 –
0.89 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 151.9, 151.5, 151.4, 150.8,
150.4, 149.9, 145.6, 139.0, 138.8, 130.4, 130.3, 129.9, 128.5, 128.3,
126.3, 126.2, 125.7, 125.6, 124.6 124.3, 124.2, 121.1, 115.9, 111.3,
111.0, 109.6, 69.9, 69.7, 68.8, 32.2, 31.9, 29.9, 29.7, 26.3, 26.2, 22.9,
14.4. IR (cm−1): 2925, 2856, 2320, 1591, 1498, 1416, 1204, 966, 803,
517. HRMS (MALDI): m/z [M+H]+ calcd for C87H112N3O6 1295.8629,
found 1295.8624.
4,4',4''-((1E,1'E,1''E)-(((1E,1'E,1''E)-benzene-1,3,5-triyltris(ethene-2,1-
diyl))tris(2,5-bis(hexyloxy)benzene-4,1-diyl))tris(ethene-2,1-
2,5-Bis(hexyloxy)-4-(2-(pyridin-4-yl)vinyl)benzaldehyde (5). According
to GP1 a solution of monoaldehyde 3 (385 mg, 1.00 mmol), 4-
vinylpyridine (214 mg, 1.14 mmol), Pd(OAc)2 (11.2 mg, 50.0 μmol), tris(o-
tolyl)phosphine (30.4 mg, 100 μmol) and triethylamine (0.7 mL) in DMF
(10 mL) was stirred at 110 °C for 48 h. Column chromatography (silica
gel, PE/EA = 5:1, Rf = 0.20) afforded 5 as a yellow viscous oil (343 mg,
840 μmol, 84%). 1H NMR (300 MHz, CDCl3) δ 10.59 (s, 1H), 8.73 (d, J =
5.2 Hz, 2H), 7.78 (d, J = 16.5 Hz, 1H), 7.52 (d, J = 5.6 Hz, 2H), 7.47 (s,
1H), 7.30 (t, J = 8.2 Hz, 2H), 4.24 (t, J = 6.5 Hz, 2H), 4.16 (t, J = 6.5 Hz,
2H), 2.11 – 1.90 (m, 4H), 1.72 – 1.27 (m, 14H), 1.05 (dd, J = 6.4, 4.4 Hz,
6H). 13C NMR (125 MHz, CDCl3) δ 189.1, 156.0, 151.1, 150.2, 144.7,
132.7, 129.4, 127.6, 125.1, 121.1, 111.3, 110.3, 69.3, 69.2, 31.6, 29.2,
25.9, 22.7, 14.1. IR (cm−1): 2928, 2857, 1676, 1601, 1422, 1206, 1018,
529. HRMS (DART): m/z [M+H]+ calcd for C26H36NO3 410.2690, found
410.2687.
diyl))tris(N,N-dibutylaniline) (YNBu). According to GP2 a solution of
triphosphonate 7 (42.3 mg, 80.0 µmol) in dry THF (8 mL) was treated
with NaH (28.8 mg, 1.20 mmol) and monoaldehyde 6 (137 mg, 256 µmol)
was added. The crude product was purified by column chromatography
(silica gel, PE/DCM = 2:1 + 2% triethylamine, Rf = 0.45) to yield the
desired compound YNBu as an orange viscous oil (90.9 mg, 54.3 µmol,
68%).1H NMR (600 MHz, CDCl3) δ 7.61 – 7.37 (m, 5H), 7.33 (d, J = 8.4
Hz, 4H), 7.26 – 7.03 (m, 11H), 7.03 – 6.89 (m, 4H), 6.82 – 6.65 (m, 1H),
6.62 – 6.15 (m, 7H), 4.16 – 3.60 (m, 12H), 3.18 (m, 12H), 1.92 – 1.63 (m,
12H), 1.48 (m, 24H), 1.41 – 1.26 (m, 24H), 1.25 – 1.07 (m, 12H), 0.95 –
0.73 (m, 36H). 13C NMR (150 MHz, CDCl3) δ 153.4, 151.4, 150.8, 147.8,
146.5, 138.9, 131.0, 130.3, 129.2, 128.6, 128.4, 128.3, 127.9, 127.7,
125.9, 125.8, 125.3, 124.3, 124.1, 118.4, 115.4, 114.0, 112.6, 112.0,
111.7, 111.2, 110.1, 69.8, 50.9, 31.8, 29.6, 27.8, 26.1, 22.8, 20.5, 16.0,
14.2. IR (cm−1): 2953, 2926, 2857, 1607, 1519, 1366, 1185, 1030, 962,
805, 523. HRMS (MALDI): m/z [M+H]+ calcd for C114H165N3O6 1673.2777,
found 1673.293. Elemental analysis calcd. (%) for C114H165N3O6: C
81.82; H 9.94; N 2.51; found: C 81.60, H 10.76, N 2.45.
4-(4-(Dibutylamino)styryl)-2,5-bis(hexyloxy)benzaldehyde
(6).
According to GP1 a solution of monoaldehyde 3 (771 mg, 2.00 mmol), 4-
dibutylaminostyrene (509 mg, 2.20 mmol), Pd(OAc)2 (22.4 mg, 100 μmol),
tris(o-tolyl)phosphine (60.9 mg, 200 μmol) and triethylamine (1.5 mL) in
DMF (20 mL) was stirred at 110 °C for 48 h. Column chromatography
This article is protected by copyright. All rights reserved.